迪馬股份(600565.SH):共同成長計劃第二期首次買入2636.7598萬股
格隆匯 8 月 25日丨迪馬股份(600565.SH)披露共同成長計劃第二期實施的進展,收到共同成長計劃管理人通知:2020年8月25日,資管計劃通過二級市場首次買入迪馬股份股票共計2636.7598萬股,佔公司總股本的1.08%。
按照相關法律法規及共同成長計劃的要求,在提取上述共同成長計劃資金完成之日起的6個月內(即2021年1月23日前),公司共同成長計劃第二期將繼續通過資管計劃按照共同成長計劃規定的股票獲取方式完成迪馬股份(標的股份)的買入,並根據市場情況在符合相關法律法規的情況下進行合理配資。公司將嚴格履行窗口期相關禁止規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.